ASCEND BY NTHRYS
Research Abroad Products

Applied Immunology Project Topics

Browse all focused areas across all project categories under this field.

Showing 145–156 of 200 project topics
Personalized Vaccine Response and Immunogenicity Assessment Analytics Platform
A commercial testing platform that measures post-vaccination T-cell and B-cell responses, neutralizing antibody titers, and protective immunity durability for infectious disease vaccines. Pharmaceutical companies, clinical research organizations, and hospitals purchase licenses to accelerate vaccine development timelines and personalize booster recommendations.
Infectious Disease Immune Response Analytics Click to view more details →
Immune Exhaustion and Persistent Infection Monitoring for Chronic Viral Diseases
A subscription-based laboratory service that tracks PD-1, TIM-3, and LAG-3 immune checkpoint markers to monitor immune dysfunction in chronic hepatitis, HIV, and CMV infections. Specialty care providers and infectious disease clinics subscribe to this service to optimize immunotherapy timing and capture premium reimbursement for precision immune monitoring.
Infectious Disease Immune Response Analytics Click to view more details →
Rapid Fungal and Atypical Pathogen Immune Signature Identification Tool
A proprietary testing platform that identifies fungal and atypical infections through distinctive host immune cytokine and chemokine profiles paired with molecular confirmation, enabling diagnosis in immunocompromised patients within 24-48 hours. Diagnostic reference labs commercialize this as a premium add-on service for immunocompromised patient populations, driving higher-margin test revenue.
Infectious Disease Immune Response Analytics Click to view more details →
Nosocomial Infection Risk Prediction Using Hospital-Wide Immune Surveillance
An enterprise software platform that aggregates patient immune profiles, environmental pathogen data, and clinical records to predict hospital-acquired infection outbreaks and identify high-risk individuals. Healthcare networks implement this to reduce infection-related readmissions, qualify for quality incentive payments, and optimize infection prevention staffing.
Infectious Disease Immune Response Analytics Click to view more details →
Transplant Infection Monitoring Through Dynamic Immune Reconstitution Profiling
A specialized SaaS analytics platform that tracks CD4+ recovery, immune cell diversity, and opportunistic pathogen risk in transplant recipients through longitudinal immunophenotyping and biomarker surveillance. Transplant centers and post-acute care providers license this for continuous monitoring to prevent life-threatening infections and improve patient outcomes, capturing premium diagnostic fees.
Infectious Disease Immune Response Analytics Click to view more details →
Immunological Biomarker Testing Suite for Treatment Response and Prognosis in Infection
A comprehensive commercial laboratory service offering multi-panel immune biomarker testing including procalcitonin, CRP, lymphocyte subset counts, and activation markers to predict clinical recovery in bacterial, viral, and fungal infections. Diagnostic companies and hospital networks build recurring revenue through longitudinal testing protocols that improve clinical decision-making and reduce treatment failures.
Infectious Disease Immune Response Analytics Click to view more details →
Mucosal Tissue Model SaaS Platform for Drug Screening
A cloud-based software platform that provides virtual 3D mucosal tissue models (intestinal, respiratory, nasal) for high-throughput immunological drug candidate screening. Delivers recurring revenue through subscription tiers while reducing client R&D costs by 40-60% compared to traditional animal testing.
Mucosal Immunology Drug Development Platforms Click to view more details →
Oral Immunogenicity Prediction Tool with Machine Learning
An AI-powered diagnostic tool that predicts oral vaccine and therapeutic immunogenicity using patient microbiome and mucosal barrier data. Generates revenue through licensing to pharmaceutical companies and enables faster clinical trial design with 25-35% improved success rates.
Mucosal Immunology Drug Development Platforms Click to view more details →
Gut-Associated Lymphoid Tissue Engineering Service
A contract manufacturing service that produces custom GALT-mimetic bioreactors and organoid systems for vaccine and immunotherapy developers. Monetizes through per-unit manufacturing fees plus tiered service packages for assay development and validation support.
Mucosal Immunology Drug Development Platforms Click to view more details →
Mucosal Adjuvant Efficacy Ranking Database and API
A comprehensive commercial database with API access containing efficacy rankings and mechanisms for 500+ mucosal adjuvants across delivery routes and target tissues. Delivers B2B revenue through institutional subscriptions and white-label licensing to CROs and pharmaceutical partners.
Mucosal Immunology Drug Development Platforms Click to view more details →
Intranasal and Pulmonary Delivery Optimization Platform
A proprietary software-hardware platform that optimizes aerosol particle size, deposition patterns, and mucosal immune activation for intranasal and inhaled therapeutics. Captures revenue through platform licensing fees plus performance-based royalties on commercialized drug products.
Mucosal Immunology Drug Development Platforms Click to view more details →
Oral Tolerance Prediction and Mitigation Software Suite
A commercial software system that predicts oral tolerance development risks in mucosal vaccines and provides formulation recommendations to prevent immune dampening. Sells to vaccine manufacturers and biotech firms as a subscription service with consultation packages.
Mucosal Immunology Drug Development Platforms Click to view more details →